Evidence map›Paper›PMID 39124652›Full record

ArticleJournal of clinical medicine2024

Impact of Serum Indoxyl Sulfate on One-Year Adverse Events in Chronic Kidney Disease Patients with Heart Failure.

Keiichiro Iwasaki, Toru Miyoshi, Chikara Urabe, Satoru Sakuragi, Yusuke Kawai, Soichiro Fuke, Masayuki Doi, Atsushi Takaishi, Takefumi Oka, Naoto Tokunaga and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Keiichiro IwasakiDepartment of Cardiovascular Medicine, Okayama University Institute of Academic and Research, Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.ORCID 0000-0002-5104-4180
Toru MiyoshiDepartment of Cardiovascular Medicine, Okayama University Institute of Academic and Research, Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.ORCID 0000-0002-9039-3439
Chikara UrabeDepartment of Cardiovascular Medicine, Okayama University Institute of Academic and Research, Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Satoru SakuragiDepartment of Cardiovascular Medicine, Iwakuni Clinical Center, Iwakuni 740-8510, Japan.
Yusuke KawaiDepartment of Cardiovascular Medicine, Okayama City Hospital, Okayama 700-8558, Japan.
Soichiro FukeDepartment of Cardiovascular Medicine, Japanese Red Cross Okayama Hospital, Okayama 700-8558, Japan.
Masayuki DoiDepartment of Cardiology, Kagawa Prefectural Central Hospital, Takamatsu 760-8557, Japan.
Atsushi TakaishiDepartment of Cardiology, Mitoyo General Hospital, Kanonji 769-1695, Japan.
Takefumi OkaDepartment of Cardiology, Tsuyama Chuo Hospital, Tsuyama 708-0841, Japan.
Naoto TokunagaDepartment of Cardiology, Ibara City Hospital, Ibara 715-0019, Japan.
Hiroshi ItoDepartment of General Internal Medicine 3, Kawasaki Medical School, Okayama 700-8558, Japan.

Funding

KUREHA Corporation N/A
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic kidney diseaseheart failureindoxyl sulfate

Identifiers

PMID39124652
PMCPMC11313553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.